About Ellume
Ellume is a company based in Brisbane (Australia) founded in 2010 by Sean Parsons. Ellume has raised $5 million across 2 funding rounds from investors including HHS and U.S. Department of Defense. Ellume offers products and services including Betting Reviews and Casino Guides. Ellume operates in a competitive market with competitors including Souzhou Ribo Life Science, PathoQuest, GNA Biosolutions, Quantalife and Senzo, among others.
- Headquarter Brisbane, Australia
- Founders Sean Parsons
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ellume Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 2 rounds
-
Latest Funding Round
$230 M (USD), Grant
Feb 01, 2021
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ellume
Ellume offers a comprehensive portfolio of products and services, including Betting Reviews and Casino Guides.
Platform for comparing international betting sites and bonuses.
Guides on unlicensed casinos with payment options and odds.
People of Ellume
Unlock access to complete
Unlock access to complete
Funding Insights of Ellume
Ellume has successfully raised a total of $5M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $230 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ellume
Ellume has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and U.S. Department of Defense.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Military forces are provided by the U.S. Department of Defense for national security.
|
Locked | Locked | Locked |
Investor details for Ellume
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ellume
Investment portfolio details for Ellume
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ellume
Detailed financials for Ellume
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ellume Comparisons
Peer comparison for Ellume
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ellume
Ellume operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, PathoQuest, GNA Biosolutions, Quantalife and Senzo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| Locked | Locked | Locked |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| Locked | Locked | Locked |
Instruments and assays for molecular pathogen detection are developed.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Biopreservation platform for mammalian cells and biologics is developed.
|
Detailed competitors of Ellume
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ellume
Complete news archive for Ellume
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ellume
Ellume was founded in 2010 and raised its 1st funding round 9 years after it was founded.
Ellume is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.
Ellume is a funded company, having raised a total of $5M across 2 funding rounds to date.
Ellume has is a developer of a diagnostic device that uses quantum dot fluorescent nanoparticles as biological detectors. It provides real-time patient testing with features such as encrypted patient data and images, connectivity to access user information, and claims to provides results in approximately seven minutes. The company has developed tests for Influenza AB, Respiratory Syncytial Virus, Group A Streptococcus, and aims to create tests for more respiratory viruses and bacterial infections.
Ellume's top competitors include Souzhou Ribo Life Science, Tethis and Quantalife.
Ellume offers Betting Reviews and Casino Guides.
Ellume has 2 investors. Key investors include HHS, and U.S. Department of Defense.